Biotech 2009 will include tracks on topics relevant to the Mid-Atlantic region's bioscience industry.  They include: 

Monday, November 16, 2009

Drug Delivery, Device, and Diagnostics

• The Evolving Role of Diagnostics in Bioscience Technology and Health Care
• New Trends in Drug Delivery of Biotechnology-Derived Therapeutics
• Advancements for the Diagnosis and Treatment of Neurological Disorders

Growth Strategies for Bioscience Companies

• Virtues and Vices of Being Virtual
• Creative Partnering:  How to Thrive in the "New Normal"
• Developing Value for Your Exit Strategy

Regulatory

• Biosimilars - Challenges and Opportunities
• The FDA Amendments Act of 2007 - What You Need to Know About the Ongoing Implementation
• FDA and Industry Interactions in the Face of a Developing Pandemic

Tuesday, November 17, 2009

Communications

• Trends and Tactics:  How Bioscience Companies are Harnessing Social Media to Reach Key Audiences
• Creating and Delivering the Message:  Advanced Lessons in Reputation Management
• Communicating Value During Times of Uncertainty:  What to Do When No One Is Listening

Finance

• Navigating the Capital Markets Including Biotech IPO Opportunities:  When Will the Window Open? 
• Extending the Runway - Strategies to Preserve Cash and Obtain Non-Dilutive Financing
• Creative Financing Transactions - The Emergence of Financing Partners from Collaborative Relationships Including Structured Deals

Hot Topics in Business

• Redefined Role of Venture Capitalists:  Matching Management with Products
• Impact of Health Care Reform on Biotech, Medical Device, and Pharmaceutical Companies
• Building Value in a Development-Stage Biotech Company

Hot Topics in Science

• Immunotherapeutics:  Harnessing Innate Immunity for the Treatment of Infectious, Inflammatory, and Autoimmune Diseases
• Regenerative Medicine for Brain Injury:  From the Battlefield to the Clinic
• New Frontiers:  Mitochondrial Dysfunction, Dysregulation, and Modulation